Skip to main content
XFOR logo

XFOR · X4 Pharmaceuticals, Inc

$3.95 +0.02 (+0.51%)
Market Cap
$370.68M
Shares
94.32M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-01-24 Baldry Mark 29,159
2025-01-24 Ragan Paula 76,473
2025-01-24 Taveras Arthur 24,828
2025-01-24 Arbet-Engels Christophe 11,624
2025-01-24 DiBiase Mary 22,258
2025-01-24 Mostafa Adam S. 74,773
2024-11-15 Ragan Paula 31,897
2024-10-15 Ragan Paula 31,897
2024-10-07 Taveras Arthur 76,920
2024-10-07 Baldry Mark 11,127
2024-10-07 Ragan Paula 239,436
2024-10-07 DiBiase Mary 67,695
2024-10-07 Mostafa Adam S. 230,645
2024-09-09 DiBiase Mary 2,642
2024-03-11 Ragan Paula 49,678
2024-03-11 DiBiase Mary 15,409
2024-03-11 Mostafa Adam S. 52,500
2024-03-11 Taveras Arthur 14,235
2024-02-12 DiBiase Mary 3,683
2024-02-12 Ragan Paula 21,695
2024-02-12 Taveras Arthur 787
2024-02-12 Mostafa Adam S. 27,721
2023-11-03 Ragan Paula 39,906
2023-11-01 Ragan Paula 199,531
2023-11-01 Mostafa Adam S. 230,645
2023-11-01 DiBiase Mary 67,695
2023-11-01 Baldry Mark 10,257
2023-11-01 Taveras Arthur 67,695
2023-09-08 DiBiase Mary 2,642
2023-06-30 DiBiase Mary 464
2023-06-30 Mostafa Adam S. 2,641
2023-06-23 Mostafa Adam S. 5,417
2023-06-23 Ragan Paula 6,724
2023-06-23 DiBiase Mary 857
2023-06-15 DiBiase Mary 857
2023-06-15 Ragan Paula 6,724
2023-06-15 Mostafa Adam S. 5,417
2023-05-31 Ragan Paula 6,292
Showing 1–38 of 38 filings
Key facts CIK 1501697 CUSIP 98420X202 13F (30d) 5 filings 5 filers Visit website Investor relations